Differential Expression of MiRNA in Histological Subtype of Wilms Tumor

Overview

Journal Pediatr Surg Int

Specialties General Surgery
Pediatrics

Date 2021 Oct 21

PMID 34674019

Citations 3

Authors

Disha Kakkar

Saumyaranjan Mallick

Aijaz Ahmad

Ansh Goswami

Sandeep Agarwala

Aditya Kumar Gupta

V Sreenivas

Sameer Bakhshi

K Devasenathipathy

Sandeep Mathur

Deepali Jain

Rachana Seth

Venkateswaran K Iyer

Affiliations

Soon will be listed here.

Abstract

Introduction: Wilms tumor is the most common renal malignancy in children and difficult to differentiate from other paediatric abdominal tumors radiologically, necessitating an invasive procedure for diagnosis. Previous studies have shown the potential role of miRNA as biomarkers for diagnosis, histological subtyping and prognosis. In this study, we are exploring the role of miRNA in the histological subtyping of Wilms tumor in the Indian population.

Materials And Methods: A total of 15 cases of Wilms tumor were evaluated for global miRNA expression analysis by microarray. Total RNA was extracted from fresh frozen tumor and miRNA expression analysis was performed using Agilent platform. Unsupervised clustering was done to analyse the data.

Results: Using unpaired student T test, top 10 significantly differentially expressed miRNA were selected which could differentiate among different histological subtypes by unsupervised hierarchical clustering and principal component analysis. The presence of necrosis, heterologous differentiation led to change in miRNA expression profile and led to a distinct cluster formation.

Conclusions: A panel of 5 miRNAs (miR1, 133b, 299-3p, 499a-5p, 491-3p) could differentiate among different histological subtypes of Wilms tumor, thus avoiding an invasive procedure in children, however, further confirmation using real time PCR analysis will be needed.

Citing Articles

MicroRNAs in idiopathic childhood nephrotic syndrome.

Sinha A, Sra M, Ahmed A, Mallick S, Saini H, Devi K Clin Exp Nephrol. 2024; .

PMID: 39630311 DOI: 10.1007/s10157-024-02595-3.

Circulating microRNA profiles in Wilms tumour (WT): A systematic review and meta-analysis of diagnostic test accuracy.

Benlhachemi S, Abouqal R, Coleman N, Murray M, Khattab M, El Fahime E Noncoding RNA Res. 2023; 8(3):413-425.

PMID: 37305178 PMC: 10247954. DOI: 10.1016/j.ncrna.2023.05.007.

Evaluation and management of "low" anorectal malformation in male children: an observational study.

Shandilya G, Pandey A, Pant N, Singh G, Kumar A, Rawat J Pediatr Surg Int. 2021; 38(2):337-343.

PMID: 34705061 DOI: 10.1007/s00383-021-05035-5.

References

Perez-Linares F, Perezpena-Diazconti M, Garcia-Quintana J, Baay-Guzman G, Cabrera-Munoz L, Sadowinski-Pine S . MicroRNA Profiling in Wilms Tumor: Identification of Potential Biomarkers. Front Pediatr. 2020; 8:337. PMC: 7378594. DOI: 10.3389/fped.2020.00337. View

Ludwig N, Werner T, Backes C, Trampert P, Gessler M, Keller A . Combining miRNA and mRNA Expression Profiles in Wilms Tumor Subtypes. Int J Mol Sci. 2016; 17(4):475. PMC: 4848931. DOI: 10.3390/ijms17040475. View

Ludwig N, Nourkami-Tutdibi N, Backes C, Lenhof H, Graf N, Keller A . Circulating serum miRNAs as potential biomarkers for nephroblastoma. Pediatr Blood Cancer. 2015; 62(8):1360-7. DOI: 10.1002/pbc.25481. View

Li J, Liu X, Wang W, Li C . miR-133a-3p promotes apoptosis and induces cell cycle arrest by targeting CREB1 in retinoblastoma. Arch Med Sci. 2020; 16(4):941-956. PMC: 7286343. DOI: 10.5114/aoms.2019.86901. View

Dang S, Zhou J, Wang Z, Wang K, Dai S, He S . MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma. Biomed Pharmacother. 2018; 106:966-975. DOI: 10.1016/j.biopha.2018.06.042. View

Gutierrez-Camino A, Lopez-Lopez E, Martin-Guerrero I, Pinan M, Garcia-Miguel P, Sanchez-Toledo J . Noncoding RNA-related polymorphisms in pediatric acute lymphoblastic leukemia susceptibility. Pediatr Res. 2014; 75(6):767-73. DOI: 10.1038/pr.2014.43. View

Zhang X, Gee H, Rose B, Lee C, Clark J, Elliott M . Regulation of the tumour suppressor PDCD4 by miR-499 and miR-21 in oropharyngeal cancers. BMC Cancer. 2016; 16:86. PMC: 4750294. DOI: 10.1186/s12885-016-2109-4. View

Liu X, Zhang Z, Sun L, Chai N, Tang S, Jin J . MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4. Carcinogenesis. 2011; 32(12):1798-805. DOI: 10.1093/carcin/bgr213. View

Sun R, Liu Z, Tong D, Yang Y, Guo B, Wang X . miR-491-5p, mediated by Foxi1, functions as a tumor suppressor by targeting Wnt3a/β-catenin signaling in the development of gastric cancer. Cell Death Dis. 2017; 8(3):e2714. PMC: 5386537. DOI: 10.1038/cddis.2017.134. View

10.

Denoyelle C, Lambert B, Meryet-Figuiere M, Vigneron N, Brotin E, Lecerf C . miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation. Cell Death Dis. 2014; 5:e1445. PMC: 4649504. DOI: 10.1038/cddis.2014.389. View

11.

Qi W, Gao C, Zhang L, Gao Z, Sui J, Han C . MiR-3196, a p53-responsive microRNA, functions as a tumor suppressor in hepatocellular carcinoma by targeting FOXP4. Am J Cancer Res. 2020; 9(12):2665-2678. PMC: 6943357. View

12.

Meister J, Schmidt M . miR-126 and miR-126*: new players in cancer. ScientificWorldJournal. 2010; 10:2090-100. PMC: 5763667. DOI: 10.1100/tsw.2010.198. View

13.

Wang C, Zhou B, Liu M, Liu Y, Gao R . miR-126-5p Restoration Promotes Cell Apoptosis in Cervical Cancer by Targeting Bcl2l2. Oncol Res. 2017; 25(4):463-470. PMC: 7841031. DOI: 10.3727/096504016X14685034103879. View

14.

Zhang C, Li L, She C, Xie Y, Ge D, Dong Q . MiR-299-5p targets cell cycle to promote cell proliferation and progression of osteosarcoma. Eur Rev Med Pharmacol Sci. 2018; 22(9):2606-2613. DOI: 10.26355/eurrev_201805_14954. View

15.

Wu Y, Wan X, Ji F, Song Z, Fang X . Serum miR-658 induces metastasis of gastric cancer by activating PAX3-MET pathway: A population-based study. Cancer Biomark. 2018; 22(1):111-118. DOI: 10.3233/CBM-171045. View

16.

Gao S, Chen L, Lu W, Zhang L, Wang L, Zhu H . miR-888 functions as an oncogene and predicts poor prognosis in colorectal cancer. Oncol Lett. 2018; 15(6):9101-9109. PMC: 6004656. DOI: 10.3892/ol.2018.8461. View

17.

Watson J, Bryan K, Williams R, Popov S, Vujanic G, Coulomb A . miRNA profiles as a predictor of chemoresponsiveness in Wilms' tumor blastema. PLoS One. 2013; 8(1):e53417. PMC: 3538586. DOI: 10.1371/journal.pone.0053417. View

18.

Wang H, Zhang Y, Zhuang H, Xu M . MicroRNA-613 attenuates the proliferation, migration and invasion of Wilms' tumor via targeting FRS2. Eur Rev Med Pharmacol Sci. 2017; 21(15):3360-3369. View

19.

Liu C, Wang W, Sun Y, Zhuang H, Xu M, Chen H . MiR-144-3p inhibits the proliferation and metastasis of pediatric Wilms' tumor cells by regulating Girdin. Eur Rev Med Pharmacol Sci. 2018; 22(22):7671-7678. DOI: 10.26355/eurrev_201811_16384. View

20.

Su H, Wang X, Song J, Wang Y, Zhao Y, Meng J . MicroRNA-539 inhibits the progression of Wilms' Tumor through downregulation of JAG1 and Notch1/3. Cancer Biomark. 2018; 24(1):125-133. PMC: 6398546. DOI: 10.3233/CBM-181972. View